Follow the 중앙첨단소재 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 중앙첨단소재 has published 60 reports. Market capitalisation: €106.8bn. The latest transaction was reported on 26 March 2026 (Other). Among the most active insiders: 아틀라스팔천. The full history is free.
60
Insider Decl.
n/a
Thresholds
n/a
8 ops.
Buy Volume
n/a
20 ops.
Sell Volume
5Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 23,177 of 28,958 companies
30.6
score / 100
Value
37
Quality
25
FCF yld2.1%
Earn yld-4.7%
EV/EBITDA·
ROE-3.6%
Gross mgn30%
Net mgn-28%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
중앙첨단소재 is a company specializing in the health and pharmaceutical sector, listed on the XKRX. It focuses on the development of advanced materials for medical applications.